UNSW & Garvan Institute Take Precision Medicine Revolution to War Against Pancreatic Cancer in Australia
Thanks to an $3.75 million grant injection from the Cancer Institute, NSW Translational Program, researchers and clinicians from UNSW and […]
Thanks to an $3.75 million grant injection from the Cancer Institute, NSW Translational Program, researchers and clinicians from UNSW and […]
An Erasmus MC biotech venture spin-off was announced recently in Rotterdam, Netherlands. Pan Cancer T B.V., founded by Prof. Dr. […]
The U.S. Food and Drug Administration decided to open the Orphan Drug Designation (ODD) to an investigational drug for the […]
IO Biotech, a Danish clinical-stage biotech venture developing novel, immune-modulating anti-cancer therapies based on its proprietary T-win® technology raised EUR […]
A 46 year-old man residing in the Louisville, Kentucky area was given about six months to live, according to a […]
French pharmaceutical giant Sanofi has made an offer to acquire Kiadis, a clinical-stage biotech company developing what they refer to […]
Ose Immunotherapeutics will conduct a clinical trial involving up to 400 patients for an experimental COVID-19 vaccine it hopes can […]
Cancer researchers at Children’s Hospital of Philadelphia (CHOP) have harnessed tools used for the development of cancer immunotherapies and adapted them to identify […]
The diagnosis of Glioblastoma, an aggressive tumor of the central nervous system, changes life as we know it. Upon the initial […]
Shanghai-based I-Mab was cleared by the U.S. Food and Drug Administration to conduct a Phase I clinical trial to assess […]